ArticleScientific reports2025
The value of nomogram analysis in predicting pulmonary metastasis in hepatic alveolar echinococcosis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Alveolar Echinococcosis in the Early 2020s: A Systematic Review.Pathogens (Basel, Switzerland) · 2026Pooled it
- Conserved surface-exposed linear epitopes of Echinococcus multilocularis thioredoxin peroxidase enable non-invasive diagnosis of alveolar echinococcosis in intermediate host.PLoS neglected tropical diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatic alveolar echinococcosis (HAE) is a rare zoonotic parasitic disease that closely resembles malignant tumors in both behavior and appearance. It can cause infiltration of affected organs and chronic liver damage. In advanced stages, it may metastasize or invade surrounding organs, resembling liver cancer, and is clinically referred to as "parasitic cancer." However, the prognosis of HAE with pulmonary metastasis is poor, and no reliable method currently exists to predict lung metastasis. This study aims to investigate the efficacy of a nomogram model, based on CT and MRI imaging features in conjunction with clinical indicators, for predicting pulmonary metastasis in HAE. A retrospective analysis was conducted using imaging and clinical data from 297 patients diagnosed with HAE. Univariate and multivariate logistic regression analyses identified independent factors associated with pulmonary metastasis, including lesion size, the presence of metastasis to other organs, cavitary lesions, and enhancement characteristics. The nomogram, developed using these variables, demonstrated strong predictive performance in both the training and validation cohorts. This model provides an effective tool for predicting the risk of pulmonary metastasis, offering early insights into disease progression and assisting clinicians in formulating personalized treatment and prognostic plans.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.